Support Alert

Chloroquine and Hydroxychloroquine not licensed for coronavirus (COVID-19) treatment

MHRA have issued a press release around recent media reports that have suggested that chloroquine can protect patients from coronavirus or treat COVID-19, the illness caused by a coronavirus. Chloroquine and hydroxychloroquine are not licensed to treat COVID-19 related symptoms or prevent infection.

Clinical trials are ongoing to test chloroquine and hydroxychloroquine as an agent in the treatment of COVID-19 or to prevent COVID-19 infection. These clinical trials are still not completed, so no conclusions have been reached on the safety and effectiveness of this medicine to treat or prevent COVID-19.

Until we have clear, definitive evidence these treatments are safe and effective for the treatment of COVID-19, they should only be used for this purpose within a clinical trial

Further details of the press release can be found on the MHRA website


Loading...

Spread the cost of your membership

Stageofcareerqualify3

With the recent cost of living rises, we’re all making savings wherever we can – and you can do the same with your RPS membership.

Instead of paying for everything all at once, make life easier by paying monthly. After all, you use your RPS membership benefits all year round, so it makes sense to pay for them the same way.

With monthly Direct Debit, you only have a small, regular payment each month. It’s the easy way to keep practicing at your best, without making a hole in your finances!

Spread the cost of your membership - join by monthly Direct Debit today.

FIND OUT MORE